Application of hydroxyapatite nanoparticles in development of an enhanced formulation for delivering sustained release of triamcinolone acetonide
Saeid Koocheki1, Sayed Siavash Madaeni1, Parisa Niroomandi21Membrane Research Center, Chemical Engineering Department, Razi University, Kermanshah, Iran; 2Exir Pharmaceutical Co, Lorestan, Boroujerd, IranAbstract: We report an analysis of in vitro and in vivo drug release from an in situ formulation...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/94ce7bef376245538288223e4a67a2e5 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Saeid Koocheki1, Sayed Siavash Madaeni1, Parisa Niroomandi21Membrane Research Center, Chemical Engineering Department, Razi University, Kermanshah, Iran; 2Exir Pharmaceutical Co, Lorestan, Boroujerd, IranAbstract: We report an analysis of in vitro and in vivo drug release from an in situ formulation consisting of triamcinolone acetonide (TR) and poly(D,L-lactide-co-glycolide) (PLGA) and the additives glycofurol (GL) and hydroxyapatite nanoparticles (HA). We found that these additives enhanced drug release rate. We used the Taguchi method to predict optimum formulation variables to minimize the initial burst. This method decreased the burst rate from 8% to 1.3%. PLGA-HA acted as a strong buffer, thereby preventing tissue inflammation at the injection site caused by the acidic degradation products of PLGA. Characterization of the optimized formulation by a variety of techniques, including scanning electron microscopy, X-ray diffraction, differential scanning calorimetry, and Fourier transform near infrared spectroscopy, revealed that the crystalline structure of TR was converted to an amorphous form. Therefore, this hydrophobic agent can serve as an additive to modify drug release rates. Data generated by in vitro and in vivo experiments were in good agreement.Keywords: triamcinolone acetonide, glycofurol, hydroxyapatite nanoparticle, PLGA |
|---|